34 Results for "

FPPS

" in MedChemExpress (MCE) Product Catalog:
Products (34)

34 Results for "FPPS" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-16274
CAS No.: 189060-13-7
Synonyms: TAK-475
Target:  

Farnesyl Transferase

Research Areas:  

Metabolic Disease

Lapaquistat acetate (TAK-475) is a squalene synthase inhibitor, blocking the conversion of farnesyl diphosphate (FPP) to squalene in the cholesterol biosynthesis pathway . Lapaquistat acetate is effective at lowering low-density lipoprotein cholesterol, but it might cause liver damage. Lapaquistat acetate is used for hypercholesterolemia and mevalonate kinase deficiency (MKD) research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0515
CAS No.: 138926-19-9
Synonyms: BM-210955; RPR-102289A
Target:  

Apoptosis

Research Areas:  

Metabolic Disease Cancer

Ibandronate Sodium Monohydrate (BM-210955; RPR-102289A) is an orally active, selective inhibitor of farnesyl pyrophosphate synthase (FPP synthase). Ibandronate Sodium Monohydrate can block the mevalonate pathway to inhibit the isoprenylation modification of small GTPases (such as RAS, RHO family proteins), induce tumor cell apoptosis and inhibit bone resorption. Ibandronate Sodium Monohydrate inhibits tumor cell proliferation (such as ER + breast cancer cells), promotes the expression of the pro-apoptotic gene FAS, and can produce synergistic anti-tumor effects with anti-estrogen compounds. Ibandronate Sodium Monohydrate is used in the study of osteoporosis and bone metastatic tumors (such as breast cancer bone metastasis) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0515B
CAS No.: 138844-81-2
Target:  

Apoptosis

Research Areas:  

Metabolic Disease Cancer

Ibandronate Sodium is an orally active, selective inhibitor of farnesyl pyrophosphate synthase (FPP synthase). Ibandronate Sodium can block the mevalonate pathway to inhibit the isoprenylation modification of small GTPases (such as RAS, RHO family proteins), induce tumor cell apoptosis and inhibit bone resorption. Ibandronate Sodium inhibits tumor cell proliferation (such as ER+ breast cancer cells), promotes the expression of the pro-apoptotic gene FAS, and can produce synergistic anti-tumor effects with anti-estrogen compounds. Ibandronate Sodium is used in the study of osteoporosis and bone metastatic tumors (such as breast cancer bone metastasis) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16322
CAS No.: 180064-38-4
Synonyms: YM-529
Minodronic acid (YM-529) is an FPP synthase inhibitor with an IC50 of 3 nM, and also an antagonist of P2X2/3 receptors with an IC50 of 62.7 μM. Minodronic acid induces tumor cell apoptosis and inhibits cell growth. Minodronic acid also suppresses bone resorption. Minodronic acid can be used in research related to osteoporosis and cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16322A
CAS No.: 155648-60-5
Synonyms: YM-529 hydrate
Target:  

P2X Receptor Apoptosis

Research Areas:  

Metabolic Disease Cancer

Minodronic acid (YM-529) hydrate is an FPP synthase inhibitor with an IC50 of 3 nM, and also an antagonist of P2X2/3 receptors with an IC50 of 62.7 μM. Minodronic acid hydrate induces tumor cell apoptosis and inhibits cell growth. Minodronic acid hydrate also suppresses bone resorption. Minodronic acid hydrate can be used in research related to osteoporosis and cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W585869
CAS No.: 92692-39-2
Target:  

Parasite

Amorphadiene is the precursor to the antimalarial agent artemisinin, which is produced through the amorphadiene synthase (ADS)-catalyzed cyclization of farnesyl pyrophosphate (FPP) yeast .
loading...
    loading...
Cat. No.: HY-150168
CAS No.: 2260887-57-6
Purity:  95.50%
Target:  

Bacterial

Research Areas:  

Infection

TH-Z145, a lipophilic bisphosphonate, is a FPPS inhibitor (IC50: 210 nM) .
loading...
    loading...
Cat. No.: HY-N7844
CAS No.: 4294-16-0
Synonyms: Benzyladenosine
N6-Benzyladenosine is an adenosine receptor agonist, has a cytoactive activity. N6-Benzyladenosine arrests cell cycle at G0/G1 phase and induces cell apoptosis. N6-Benzyladenosine also exerts inhibitory effect on T. gondii adenosine kinase and glioma - .
loading...
    loading...
Cat. No.: HY-P11228
Research Areas:  

Cancer

FPP29 is a potent peptide-based FOXM1 PROTAC degrader. FPP29 induces ubiquitination and degradation of FOXM1. FPP29 inhibits FOXM1 via the ubiquitin-proteasome degradation pathway. FPP29 induces Apoptosis. FPP29 suppresses tumor growth in hepatocellular carcinoma xenograft models. FPP29 can be used in the research of hepatocellular carcinoma (cell-penetrating peptide: (HY-P0133); VHL ligase ligand: (HY-P11493); linker: (HY-W013664); FOXM1 ligand: (HY-P11494)) .
loading...
    loading...
Cat. No.: HY-118946
CAS No.: 5352-53-4
Purity:  99.12%
Synonyms: NSC50460
Target:  

Bacterial

Research Areas:  

Infection Cancer

BPH-1358 (NSC50460) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor with IC50s of 1.8 μM and 110 nM, respectively, and is active against S. aureus in vitro (MIC ~250 ng/mL) .
loading...
    loading...
Cat. No.: HY-150167
CAS No.: 2260887-09-8
Purity:  98.77%
Target:  

Bacterial

Research Areas:  

Infection

TH-Z93, a lipophilic bisphosphonate, is a FPPS inhibitor (IC50: 90 nM) .
loading...
    loading...
Cat. No.: HY-113752
CAS No.: 902630-14-2
Purity:  99.54%
Target:  

Parasite

Research Areas:  

Infection

MMV019313 is a potent, non-bisphosphonate inhibitor of farnesyl/geranylgeranyl diphosphate synthase (FPPS/GGPPS) with an IC50 of 0.82 µM. MMV019313 has activity against P. falciparum (Parasite) .
loading...
    loading...
Cat. No.: HY-149149
CAS No.: 124351-85-5
Purity:  98.03%
Target:  

Bacterial

Research Areas:  

Infection Metabolic Disease Cancer

Incadronic acid inhibits growth of Dictyostelium discoideum with an IC50 of 1.6 μM. Incadronic acid binds the farnesyl diphosphate synthase (FPPS) in Leishmania major with the Ki of 23 nM. Incadronic acid inhibits the bone resorption and reduces bone loss, that can be used in osteoporosis research. Incadronic acid inhibits the proliferation of cells RAW264.7, PC-3 and MCF-7 with IC50 of 48 to 228.6 µM .
loading...
    loading...
Cat. No.: HY-W013664
CAS No.: 7361-43-5
Target:  

PROTAC Linkers

Research Areas:  

Cancer

Glycyl-l-serine is a PROTAC linker composed of glycine and serine. Glycyl-l-serine can be used in the synthesis of PROTACs, such as FPP29 (HY-P11228) .
loading...
    loading...
Cat. No.: HY-P11493
CAS No.: 1260529-82-5
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

ALAPYIP is a ligand for E3 ligase. ALAPYIP recruits the VHL-E3 ubiquitin ligase. ALAPYIP can be used for the synthesis of FPP29 (HY-P11228) .
loading...
    loading...
Cat. No.: HY-P11494
Synonyms: CP29 peptide
AWWNTEW (CP29) is a FOXM1-DBD peptide ligand with cytotoxicity to cancer cells. AWWNTEW has a strong affinity and binds to the FOXM1 protein. AWWNTEW is a component of FPP29 (HY-P11228) . X
loading...
    loading...
Cat. No.: HY-163832
Target:  

Farnesyl Transferase

Research Areas:  

Metabolic Disease

FPPS-IN-2 (compound 4a) is a potent and orally active HFPPS inhibitor with an IC50 value of 1.108 µM. FPPS-IN-2 has the potential for the research of osteoporosis .
loading...
    loading...
Cat. No.: HY-117807
CAS No.: 185049-54-1
Research Areas:  

Cancer

A-176120 is a selective inhibitor of farnesyl transferase (IC50=1.2 nM) based on a farnesyl pyrophosphate (FPP) analog, with superior selectivity against GGTaseI (IC50=423 nM), GGTaseII (IC50=3000 nM), and SSase (IC50>10 μM). A-176120 inhibits ras processing in H-ras transformed NIH3T3 cells and HCT116 K-ras mutant cells (ED50=1.6 and 0.5 μM, respectively). A-176120 has antiangiogenic and antitumor activities in vivo and reduces capillary structure formation and VEGF secretion .
loading...
    loading...
Cat. No.: HY-W100829
CAS No.: 51527-19-6
Target:  

Drug Intermediate

Research Areas:  

Others

FPPS ligand 3 (compound 2) is a farnesyl pyrophosphate synthase (FPPS) ligand. FPPS ligand 3 binds to the hydrophobic base region of the FPPS pocket. FPPS ligand 3 can be used to design and synthesize FPPS inhibitors .
loading...
    loading...
Cat. No.: HY-118946B
Synonyms: NSC50460 mesylate
Target:  

Bacterial

Research Areas:  

Infection Cancer

BPH-1358 mesylate (NSC50460 mesylate) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor with IC50s of 1.8 μM and 110 nM, respectively. BPH-1358 mesylate is active against S. aureus in vitro (MIC ~250 ng/mL) .
loading...
    loading...